Japan Drug Costs to Remain Flat thru 2025, No Annual Price Cuts Necessary: EFPIA

EFPIA Japan Chairman Carsten Brunn The Japan pharmaceutical market, or the country’s drug spending, is estimated to level off over the next 10 years, growing at a compound average growth rate of 0.13% between 2013 and 2025, EFPIA Japan Chairman...read more